Table 2 The comparison of clinical management and outcomes between patients hospitalized with FluA-p and FluB-p in China, 2013–2019
From: Severity and outcomes of influenza-related pneumonia in type A and B strains in China, 2013–2019
Variable | Total (n = 1079) | FluA-p (n = 693) | FluB-p (n = 386) | P-value |
|---|---|---|---|---|
Early NAI therapy (n, %) | 385 (35.7) | 232 (33.5) | 153 (39.6) | 0.043 |
Systemic corticosteroid use during hospitalization (n, %) | 262 (24.3) | 132 (19.0) | 130 (33.7) | < 0.001 |
Complications during hospitalization | ||||
Respiratory failure | 249 (23.1) | 167 (24.1) | 82 (21.2) | 0.286 |
Heart failure | 265 (24.6) | 147 (21.2) | 118 (30.6) | 0.001 |
Septic shock | 53 (4.9) | 36 (5.2) | 17 (4.4) | 0.565 |
Acute renal failure | 39 (3.6) | 27 (3.9) | 12 (3.1) | 0.507 |
Bloodstream infection | 9 (0.8) | 8 (1.2) | 1 (0.3) | 0.121 |
Noninvasive ventilation (n, %) | 279 (25.9) | 159 (22.9) | 120 (31.1) | 0.003 |
Invasive ventilation (n, %) | 193 (17.9) | 158 (22.8) | 35 (9.1) | < 0.001 |
Vasopressor use (n, %) | 40 (3.7) | 27 (3.9) | 13 (3.4) | 0.660 |
Admittance to ICU (n, %) | 242 (22.4) | 176 (25.4) | 66 (17.1) | 0.001 |
Length of stay in hospital (days, median, IQR) | 10.0 (8.0–14.0) | 12.0 (7.0–14.5) | 10.0 (8.0–17.0) | < 0.001 |
30-day mortality (n, %) | 208 (19.3) | 136 (19.6) | 72 (18.7) | 0.698 |